Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +335.99%
#5 aPriori aPriori +116.11%
#6 Bedrock Bedrock +74.68%
#7 Cysic Cysic +47.27%
#8 Prom Prom +42.47%
#9 Playnance Playnance +34.82%
#10 COTI COTI +30.34%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Ember Therapeutics, Inc. Ember Therapeutics, Inc.

Ember Therapeutics, Inc.

EMBT
Classifica tra le azioni #42686
Ember Therapeutics, Inc. operates as a biopharmaceutical company currently in... Ember Therapeutics, Inc. operates as a biopharmaceutical company currently in its clinical development phase. Its core mission involves exploring the therapeutic applications of bone morphogenetic protein-7 (BMP-7) to engineer regenerative treatments. These innovative therapies are designed to alter the course of osteoarthritis, reverse insulin resistance, and inhibit or undo organ fibrosis in diseases such as chronic kidney disease and Alport's syndrome, alongside metabolic conditions like obesity and type 2 diabetes. Among its leading BMP-7-based drug candidates, MT-006 has successfully completed a Phase 2a clinical trial focused on osteoarthritis. Furthermore, MT-007, aimed at CKD and Alport syndrome; MT-008, specifically for Alport syndrome; and MT-009, targeting metabolic disease, have all concluded their preclinical trial phases. The company also maintains a substantial intellectual property portfolio, encompassing approximately 450 patents related to BMP-7, its associated protein families, various derivatives, novel delivery systems, specialized formulations, supporting clinical data, and materials produced under current good manufacturing practices. Ember Therapeutics, Inc. was established in 2010 and is headquartered in New York, New York.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-02-06
Capitalizzazione di mercato
$398.00
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Ember Therapeutics, Inc. (EMBT)

Categoria

Healthcare
Storico del prezzo dell'azione per Ember Therapeutics, Inc. (EMBT)
Prezzo di chiusura più alto: $0.00 il 2026-02-01

Prezzo di chiusura più basso: $1.22 il 2015-10-01
Storico del prezzo dell'azione di Ember Therapeutics, Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 0.00%
2022 -66.67%
2021 -99.96%
2020 560.19%
2019 2.24%
2018 -60.00%
2017 -59.65%
2016 -36.01%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR